Creative Planning Lowers Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Creative Planning decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.8% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 66,657 shares of the financial services provider’s stock after selling 1,245 shares during the quarter. Creative Planning owned approximately 0.13% of iShares Biotechnology ETF worth $9,705,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Blue Fin Capital Inc. lifted its stake in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after buying an additional 74 shares in the last quarter. Security National Bank of SO Dak increased its holdings in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after acquiring an additional 75 shares during the last quarter. Main Street Financial Solutions LLC increased its holdings in iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after acquiring an additional 82 shares during the last quarter. Perkins Coie Trust Co increased its holdings in iShares Biotechnology ETF by 0.3% in the 2nd quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock valued at $3,457,000 after acquiring an additional 83 shares during the last quarter. Finally, HCR Wealth Advisors increased its holdings in iShares Biotechnology ETF by 0.6% in the 2nd quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock valued at $1,847,000 after acquiring an additional 83 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.0 %

Shares of NASDAQ IBB opened at $144.00 on Wednesday. The firm’s fifty day moving average is $145.70 and its two-hundred day moving average is $139.90. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.